Advanced Viral, Ohr endocrine, dermatology, ophthalmic news

By WIR Staff | Dec 7, 2009 | 8:00 AM GMT

Ohr updated its pipeline, which includes compounds from Advanced Viral and Genaera Corp. Ohr acquired AVR118 and AVR123 from Advanced Viral